BioTechX Europe 2026 has ended. This guide stays up as the record of who was there. Next: BioTechX Europe 2027, Oct 11–13, 2027 in Basel
JJ
Johnson & Johnson Innovative Medicine at BioTechX Europe 2026
Oct 6–8, 2026 Basel, Switzerland ~3k attendees Website
Johnson & Johnson Innovative Medicine takes part in 2 sessions at BioTechX Europe 2026 in Basel. Its sessions centre on AI in clinical trials. Topics include predicting which patients are likely to drop out of a trial so teams can keep them enrolled, and, with SAS, turning long-standing clinical know-how into AI agents that coordinate R&D work.
| Organization | BioTechX Europe 2026 Attendance |
|---|---|
JJ Johnson & Johnson Innovative Medicine | |
Pharmaceutical business of Johnson & Johnson, formerly Janssen. | Talk Wed Oct 7 12:05 Orchestrating the Future of Clinical R&D: From Long-established Expertise to AI‑Driven Expert Agents How specialist AI assistants for data handling, statistics and reporting could reshape clinical research work, with human experts directing them. |
Find decision makers at Johnson & Johnson Innovative Medicine
Tell us what you sell and we’ll find the people at Johnson & Johnson Innovative Medicine most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by BioTechX or its organizers. Submit a correction